Therapeutic turnaround times for common laboratory tests in a tertiary hospital in Kenya.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 31 07 2019
accepted: 10 03 2020
entrez: 9 4 2020
pubmed: 9 4 2020
medline: 7 7 2020
Statut: epublish

Résumé

We evaluated therapeutic TAT for a tertiary hospital in Western Kenya, using a time-motion study focusing specifically on common hematology and biochemistry orders. The aim was to determine significant bottlenecks in diagnostic testing processes at the institution. A total of 356 (155 hematology and 201 biochemistry) laboratory tests were fully tracked from the time of ordering to availability of results to care providers. The total therapeutic TAT for all tests was 21.5 ± 0.249 hours (95% CI). The therapeutic TAT for hematology was 20.3 ± 0.331 hours (95% CI) while that for biochemistry tests was 22.2 ± 0.346 hours (95% CI). Printing, sorting and dispatch of the printed results emerged as the most significant bottlenecks, accounting for up to 8 hours of delay (Hematology-8.3 ± 1.29 hours (95% CI), Biochemistry-8.5 ± 1.18 hours (95% CI)). Time of test orders affected TAT, with orders made early in the morning and those in the afternoon experiencing the most delays in TAT. Significant inefficiencies exist at multiple steps in the turnaround times for routine laboratory tests at a large referral hospital within an LMIC setting. Multiple opportunities exist to improve TAT and streamline processes around diagnostic testing in this and other similar settings.

Identifiants

pubmed: 32267844
doi: 10.1371/journal.pone.0230858
pii: PONE-D-19-21599
pmc: PMC7141613
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0230858

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Int J Qual Health Care. 2008 Dec;20(6):392-9
pubmed: 18784268
Arch Pathol Lab Med. 1999 Jul;123(7):607-14
pubmed: 10388917
JAMA. 1981 May 1;245(17):1762-3
pubmed: 7218491
Arch Pathol Lab Med. 2013 Jun;137(6):805-11
pubmed: 23721276
J Eval Clin Pract. 2012 Feb;18(1):121-7
pubmed: 20860595
Indian J Clin Biochem. 2014 Oct;29(4):505-9
pubmed: 25298634
BMJ. 2015 Sep 04;351:h4672
pubmed: 26341898
Orv Hetil. 2014 Jul 13;155(28):1113-20
pubmed: 25002315
Arch Pathol Lab Med. 1997 Oct;121(10):1031-41
pubmed: 9341581
Clin Biochem Rev. 2007 Nov;28(4):179-94
pubmed: 18392122
Indian J Clin Biochem. 2010 Oct;25(4):376-9
pubmed: 21966108
Malar J. 2014 Jul 29;13:292
pubmed: 25073561
Nat Rev Microbiol. 2004 Mar;2(3):231-40
pubmed: 15083158
Nat Rev Microbiol. 2011 Mar;9(3):204-13
pubmed: 21326275
Am J Clin Pathol. 2001 Sep;116(3):311-5
pubmed: 11554156
PLoS Negl Trop Dis. 2013;7(1):e1999
pubmed: 23350001
Health Aff (Millwood). 2011 Jan;30(1):76-80
pubmed: 21209441
Arch Pathol Lab Med. 2003 Apr;127(4):456-60
pubmed: 12683874
J Infect Dis. 2011 Nov 15;204 Suppl 4:S1102-9
pubmed: 21996692
Clin Infect Dis. 2006 Feb 1;42(3):377-82
pubmed: 16392084
PLoS One. 2013 May 30;8(5):e64661
pubmed: 23737993
Qual Saf Health Care. 2010 Oct;19(5):416-9
pubmed: 20977994
Clin Lab Sci. 1999 Mar-Apr;12(2):85-9
pubmed: 10387493
Arch Pathol Lab Med. 1995 Oct;119(10):914-7
pubmed: 7487390
J Clin Diagn Res. 2014 Apr;8(4):FC05-8
pubmed: 24959450
Jt Comm J Qual Patient Saf. 2012 Apr;38(4):147-53
pubmed: 22533126
Int J Med Inform. 2007 Jul;76(7):514-29
pubmed: 16567121

Auteurs

Thomas Mwogi (T)

Centre for International Health, University of Bergen, Bergen, Norway.
Directorate of Medicine, Moi Teaching and Referral Hospital, Eldoret, Uasin Gishu, Kenya.
Institute of Biomedical Informatics, Moi University, Eldoret, Uasin Gishu, Kenya.

Tim Mercer (T)

Department of Population Health, The University of Texas at Austin Dell Medical School, Austin, Texas, United States of America.

Dan N Tina Tran (DNT)

Department of Pharmacy Practice, College of Pharmacy, Purdue University, West Lafeyette, IN, United States of America.

Ronald Tonui (R)

Department of Immunology, Moi University, Eldoret, Uasin Gishu, Kenya.
Laboratory Services Division, Moi Teaching and Referral Hospital, Eldoret, Kenya.

Thorkild Tylleskar (T)

Centre for International Health, University of Bergen, Bergen, Norway.

Martin C Were (MC)

Department of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville, TN, United States of America.
Vanderbilt Institute for Global Health, Nashville, TN, United States of America.
Institute of Biomedical Informatics, Moi University, Eldoret, Uasin Gishu, Kenya.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH